Beijing Balance Medical Technology Co., Ltd. (688198.SH): Innovative product valved patch for complex congenital heart disease approved for registration

Beijing Balance Medical Technology Co., Ltd. (688198.SH) announced that recently, following review by the National Medical Products Administration, the company's independently developed innovative product, a valved patch for complex congenital heart disease (National Medical Device Registration No. 20263131971), has been approved for registration. The product uses bovine jugular vein vessels as raw material (with natural venous valves), which are trimmed and sewn together with bovine pericardium patches to create the valved patch for complex congenital heart disease. The outer surface of the product is made of polyester material. The valved portion consists of one or two intact natural bovine jugular vein valves, and is available in two models: "single-valve type" and "double-valve type." The "single-valve type" with 1 bovine jugular vein valve is suitable for patients who can retain 2 of their original pulmonary valves; the "double-valve type" with 2 bovine jugular vein valves is suitable for patients who can retain 1 of their original autologous pulmonary valves.